8-KOther EventsExhibits & Filings

BOSTON SCIENTIFIC CORP 8-K Report, Corporate Update (May 18, 2026)

Filed May 18, 2026For Securities:BSX

Summary

Boston Scientific Corporation (BSX) announced on May 18, 2026, that it has entered into an Accelerated Share Repurchase (ASR) agreement for $2 billion. This ASR is part of the company's previously authorized $5 billion share repurchase program, leaving $3 billion remaining under this authorization upon completion of the ASR. The ASR involves an initial repurchase of approximately 30.4 million shares, valued at 80% of the repurchase price based on the May 15, 2026 closing price. The final number of shares repurchased will be determined by the volume-weighted average price during the ASR term, subject to discounts and adjustments. The ASR is expected to conclude by June 30, 2026, and is intended to enhance shareholder value by reducing the number of outstanding shares.

Key Highlights

  • 1Boston Scientific has initiated a $2 billion Accelerated Share Repurchase (ASR) program.
  • 2The ASR is part of a larger, previously announced $5 billion share repurchase authorization.
  • 3Upon completion of this ASR, $3 billion will remain available under the existing repurchase authorization.
  • 4The ASR will initially result in the repurchase of approximately 30.4 million shares.
  • 5The final number of shares repurchased will be based on the volume-weighted average price during the ASR term.
  • 6The ASR agreement is with JPMorgan Chase Bank, National Association.
  • 7The ASR is expected to be completed by June 30, 2026.

Frequently Asked Questions

An Accelerated Share Repurchase (ASR) is an agreement where a company buys back its own stock from a bank. The company pays a set amount, and the bank immediately delivers a portion of the shares. The final number of shares repurchased is determined later based on the market price over a specific period, potentially with adjustments.

Boston Scientific has entered into an ASR agreement for $2 billion.

The company had a $5 billion share repurchase authorization. After the completion of this $2 billion ASR, there will be $3 billion remaining under that authorization.

The final settlement and completion of the ASR are expected to occur by June 30, 2026.